Becton, Dickinson and Company

• NCT01524705

  Collaborator, Phase 4, Completed, 102 people, 2 Feb 2012

• The Case for Evaluating Continuous Glucose Monitoring as a Diagnostic Tool for Diabetes

  Consulting or advice, Board or leadership role, 8 Oct 2026

• Novel use of computed tomography-derived body composition to facilitate risk assessment in patients with bladder cancer

  Consulting or advice, 26 Sept 2026

• Elimination of HPV-associated cancers: universal HPV vaccination and the role of anal screening - a meeting report

  Grants or research support, 22 Sept 2026

• Revascularization of Asymptomatic Carotid Artery Stenosis: Cognitive Results of the CREST-2 Randomized Trials

  Fees or honoraria, 16 Sept 2026

• Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis

  Consulting or advice, Fees or honoraria, 7 Aug 2026

• Continuous map of early hematopoietic stem cell differentiation across human lifetime

  Consulting or advice, Fees or honoraria, Board or leadership role, 7 Mar 2025

Sources: pubmed.ncbi.nlm.nih.gov

• HPV-Based Cervical Cancer Screening at the Point-of-Care? A Preclinical Evaluation of the Pluslife HPV 16/18/45 Assay

  Preprints.org, 11 Sept 2026